MedPath
FDA Approval

Campath

May 3, 2023

HUMAN PRESCRIPTION DRUG LABEL

Alemtuzumab(30 mg in 1 mL)

Manufacturing Establishments (3)

Boehringer Ingelheim Pharma GmbH & Co. KG

Genzyme Corporation

340700520

Sanofi-Aventis Deutschland GmbH

Genzyme Corporation

313218430

EUROAPI UK LIMITED

Genzyme Corporation

229522842

Products (1)

Campath

58468-0357

BLA103948

BLA (C73585)

INTRAVENOUS

April 1, 2023

Code: 3A189DH42VClass: ACTIBQuantity: 30 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
MONOBASIC POTASSIUM PHOSPHATEInactive
Code: 4J9FJ0HL51Class: IACTQuantity: 0.2 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.1 mg in 1 mL
POTASSIUM CHLORIDEInactive
Code: 660YQ98I10Class: IACTQuantity: 0.2 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74Class: IACTQuantity: 1.44 mg in 1 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.0187 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath